Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trialObbina Abani, Hyacinth-John Abu, Kasim Abbas et al.|The Lancet|2023Cited by 132
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversionDavid Simón, Georg Schett, Koray Taşçılar et al.|Nature Communications|2020Cited by 87